Gliomas are the second most common type of cancer in Canada for people under the age of 40. Now, new research has found a once-a-day pill slows the growth of these tumours in many patients. Firefighter Steven Stefanidis shares his story as a research participant in the international clinical trial.
View more information about this trial, including frequently asked questions »
